Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.
Yeasts other than Candida albicans have emerged as important causes of fungal infection in hemopoietic stem cell transplant (HSCT) patients, particularly those receiving fluconazole prophylaxis. We report on an autologous hemopoietic stem cell transplant recipient who developed Candida krusei sepsis from pre-existing oral colonization.
Westbrook
Steven D
SD
Department of Dental Diagnostic Sciences, The University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA. westbrooks@uthscsa.edu
Kirkpatrick
William R
WR
Freytes
Cesar O
CO
Toro
Juan J
JJ
Bernardo
Stella
S
Patterson
Thomas F
TF
Redding
Spencer W
SW
Lee
Samuel A
SA
D000935:Antifungal Agents / Q000627:therapeutic use; D001769:Blood / Q000382:microbiology; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002177:Candidiasis / Q000150:complications* / Q000382:microbiology*; D016172:DNA Fingerprinting; D004271:DNA, Fungal / Q000235:genetics / Q000302:isolation & purification; D015725:Fluconazole / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000150:complications / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009055:Mouth / Q000382:microbiology; D009181:Mycoses / Q000517:prevention & control; D018805:Sepsis / Q000382:microbiology*; D014556:Urine / Q000382:microbiology
D000935:Antifungal Agents; D004271:DNA, Fungal; D015725:Fluconazole